Search results

The National Deuteration Facility is providing deuterated cholesterol, an essential ingredient in lipid nanoparticles for the delivery of vaccines using mRNA, to academic and industry partners.

ANSTO recently hosted a public Ask Us Anything event on nuclear medicine, sharing information on how we safely manufacture and distribute nuclear medicine across Australia each week to hundreds of hospitals and clinics.

Million year lag time in transport of sediment in Murray Darling River Basin system.

$80.2 million in new funding to expand the research capabilities of the Australian Synchrotron.

Bushfires in proximity to ANSTO during the 2018 bushfires.

BlueScope Steel Project Summary

ANSTO's Chief Nuclear Officer shares insights on the safe management of Australia's nuclear waste.

ANSTO is part of collaboration conducting experiments to redefine the kilogram linking it to a fundamental constant of nature.

ANSTO is part of a contingent showcasing Australian science at the Australian Pavilion at the World Expo Osaka in October.

Under the Government Procurement (Judicial Review) Act 2019 (Cth) ANSTO will publish Public Interest Certificates (PICs) for the current financial year where appropriate.

Five exceptional female science communicators are part of a larger team who use skills in education and engagement to promote an interest in science amongst the public and students.

Improving aquaculture for food production in Papua New Guinea

The Australian Nuclear Science and Technology Organisation (ANSTO) has joined a team, lead by the US Department of Energy’s Pacific Northwest National Laboratory (PNNL), to install a high resolution monitoring system at ANSTO’s medical isotope production facility in Lucas Heights, Australia.

The complex engineering of scientific instruments is explored in this 'behind the scenes' look at the installation of frontends for two new beamlines at the Australian Synchrotron.

Neutron scattering techniques help characterise the structure of a particle based emulsifier

University of Melbourne researchers have investigated a method to produce magnetic nanoparticles in Australia for use in COVID-19 PCR tests.